Neutrophil to lymphocyte ratio varies in magnitude and biomarker utility based on patient demographics.
Where this comes from
- Record sourced from PubMed, PMID 41217829.
- Also identified by DOI 10.1172/JCI198948 and PMC identifier 12721878.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ang et al. show that a widely studied biomarker for immunotherapy varies based on patient demographics, and that it may only predict outcomes in certain populations.
Medical subject headings
- Neutrophils
- Lymphocytes
- Neoplasms